Results 201 to 210 of about 177,182 (340)

The electrocardiogram reimagined: AI-ECG as a prognostic beacon for valvular heart disease. [PDF]

Eur Heart J
Armoundas AA.
europepmc   +1 more source

Valvular heart disease after kidney transplantation.

, 2015
Daniela Loncar, Zumreta Kušljugić, Zinka Donlagic, Irma Bijedić, Amira Bijedić, Esad Brkić, Denis Mršić, Lejla Jasarevic   +7 more
openalex   +1 more source

Guidelines for the Diagnosis and Treatment of Canine Chronic Valvular Heart Disease [PDF]

, 2009
Clarke E. Atkins, John D. Bonagura, S. Ettinger, Philip R. Fox, Sonya G. Gordon, Jens Häggström, Robert L. Hamlin, Bruce W. Keene, Virginia Luis Fuentes, Rebecca L. Stepien   +9 more
openalex   +1 more source

Lineage labeling with zebrafish hand2 Cre and CreERT2 recombinase CRISPR knock‐ins

Developmental Dynamics, EarlyView.
Abstract Background The ability to generate endogenous Cre recombinase drivers using CRISPR‐Cas9 knock‐in technology allows lineage tracing, cell type‐specific gene studies, and in vivo validation of inferred developmental trajectories from phenotypic and gene expression analyses. This report describes endogenous zebrafish hand2 Cre and CreERT2 drivers
Zhitao Ming, Fang Liu, Hannah R. Moran, Robert L. Lalonde, Megan Adams, Nicole K. Restrepo, Parnal Joshi, Stephen C. Ekker, Karl J. Clark, Iddo Friedberg, Saulius Sumanas, Chunyue Yin, Christian Mosimann, Jeffrey J. Essner, Maura McGrail   +14 more
wiley   +1 more source

Fen-phen and Valvular Heart Disease

, 1998
Alen N. Cohen
openalex   +1 more source

Association of COPD with adverse outcomes in heart failure patients with preserved ejection fraction

ESC Heart Failure, Volume 12, Issue 2, Page 799-808, April 2025.
Abstract We performed a systematic review and meta‐analysis to detect the impact of chronic obstructive pulmonary disease (COPD) on the prognosis of heart failure patients with preserved ejection fraction (HFpEF). We systematically screened eligible literature from three electronic databases, PubMed, EMBASE and Cochrane Library, up to April 2023.
Shuo Xu, Zhenbang Gu, Wengen Zhu, Shenghui Feng   +3 more
wiley   +1 more source

Chronic kidney disease and valvular heart disease: State of the art. [PDF]

Physiol Rep
Saltarocchi S, D'Abramo M, De Orchi P, Spunticchia F, Totaro M, Cirio EM, Miraldi F.   +6 more
europepmc   +1 more source

Clinical Outcomes of Transcatheter Versus Surgical Management of Coronary Artery Disease and Aortic Stenosis

Catheterization and Cardiovascular Interventions, EarlyView.
Nikolaos Ktenopoulos, Anastasios Apostolos, Konstantinos Karampinos, Panayotis Vlachakis, Antonios Karanasos, Maria Drakopoulou, Andreas Synetos, George Latsios, Konstantinos Tsioufis, Konstantinos Toutouzas   +9 more
wiley   +1 more source

Gut microbiota‐related modulation of immune mechanisms in post‐infarction remodelling and heart failure

ESC Heart Failure, Volume 12, Issue 2, Page 942-954, April 2025.
Abstract The immune system has long been recognized as a key driver in the progression of heart failure (HF). However, clinical trials targeting immune effectors have consistently failed to improve patient outcome across different HF aetiologies. The activation of the immune system in HF is complex, involving a broad network of pro‐inflammatory and ...
Johann Roessler, Friederike Zimmermann, Bettina Heidecker, Ulf Landmesser, Arash Haghikia   +4 more
wiley   +1 more source

Heterogeneity in valvular heart disease: differential predictive performance of CAR. [PDF]

Int J Surg
Gong XJ, Geng SM, Zhang YT.
europepmc   +1 more source